Position in GERN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$58,524
+$6,678 QoQ
Shares Held
39,278
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Derivatives in GERN
reported options exposure · as of Mar 31, 2026CallValue
$1,490
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Alternative Investment Advisors, LLC. holds $58,524 across 1 Biotechnology name. GERN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GERN |
Geron Corp
This page
|
39,278 | $58,524 |
All Filings in GERN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,490 | 1,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $58,524 | 39,278 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $51,846 | 39,278 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $53,810 | 39,278 | Shares | Sole | 2025-12-17 | |
| 2025-06-30 | $55,381 | 39,278 | Shares | Sole | 2025-09-08 | |
| 2025-03-31 | $62,452 | 39,278 | Shares | Sole | 2025-09-08 | |
| 2024-12-31 | $115,326 | 32,578 | Shares | Sole | 2025-09-08 | |
| 2024-09-30 | $100,828 | 22,209 | Shares | Sole | 2024-12-11 | |
| 2024-06-30 | $83,091 | 19,597 | Shares | Sole | 2024-09-26 | |
| 2024-03-31 | $33,996 | 10,302 | Shares | Sole | 2024-12-11 | |
| No filing history on record for this holder in this stock. | ||||||